Darren L Rich Dds, A Dental Corporation Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 40915 Sierra Dr Ste C, Three Rivers, CA 93271 Phone: 559-561-4445 Fax: 559-561-4446 |
News Archive
Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study presented for the first time today at ESC Congress. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year.
The NIH is actively soliciting suggestions for new initiatives to be implemented under the aegis of the NIH Roadmap. The NIH intends to spend $30-50 million/year from within the currently projected Roadmap budget for approximately 5-8 new initiatives, beginning in FY2008.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced the commencement of a Phase 1/2 clinical trial with HTI-501 (rHuCAT-L) in women with moderate to severe edematous fibrosclerotic panniculopathy (also known as cellulite).
Sunovion Pharmaceuticals Inc. today announced that a study evaluating the efficacy and safety of dasotraline in adults with moderate to severe binge eating disorder met its primary endpoint, demonstrating a statistically significant decrease in number of binge days per week from baseline to Week 12 in the group treated with dasotraline 6 mg/day versus the placebo-treated group.
The prevalence of depression among those with migraine is approximately twice as high as for those without the disease (men: 8.4% vs. 3.4%; women 12.4% vs. 5.7%), according to a new study published by University of Toronto researchers.
› Verified 9 days ago